Synthesis and anticonvulsant evaluation of N-substituted-isoindolinedione derivatives

Archives of Pharmacal Research

Volumn 27, Issue 5, 2004, Pages 495-501

  Abdel Hafez, Atef Abdel Monem ^a  

^a University of Assiut   (Egypt)

Author keywords

Anticonvulsant activity; Baclofen; Isoindolinedione; Lipophilicity; Phthalimide

Indexed keywords

ANTICONVULSIVE AGENT; INDOLE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG SCREENING; MALE; METHODOLOGY; MOUSE; SEIZURE; SYNTHESIS;

ANIMALS; ANTICONVULSANTS; DRUG EVALUATION, PRECLINICAL; INDOLES; MALE; MICE; SEIZURES;

EID: 16544388584     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980121     Document Type: Article

References (26)

1. Abd El-Wahed, M. G., El-Manakhly, K., Hammad, H., and Barakat, A., Electrical behaviour of some phthalimide derivatives and their complexes with transition metals. Bull. Korean Chem. Soc., 17, 285-288 (1996).
2. Al-Soud, Y. A. and Al-Masoudi, N. A., Synthesis and antitumor activity of some new phthalimide analogues. Pharmazie, 56, 372-375 (2001).
3. Bailleux, V., Vallée, L., Nuyts, J. P., Hamoir, G., Poupaert, J. H, Stables, J. P., and Vamecq, J., Compared the anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6 dimethylphenyl) phthalimide and prototype antiepileptic drugs in mice and rats. Epilepsia, 36, 559-565 (1994a).
4. Bailleux, V., Vallée, L., Nuyts, J. P., and Vamecq, J., Synthesis and anticonvulsant of some N-phenylphthalimides. Chem. Pharm. Bull., 42, 1817-1821 (1994b).
5. Bailleux, V., Vallée, L., Nuyts, J. P., and Vamecq, J., Original anticonvulsant properties of two N-phenylphthalimide derivatives. Biomed. Pharmacother., 47, 463-464 (1994c).
6. Bailleux, V., Vallée, L., Nuyts, J. P., and Vamecq, J., Anticonvulsant activity of some 4-amino-N-phenylphthalimides and N-(3-amino-2-methylphenyl)phthalimides. Biomed. Pharmacother., 48, 95-101 (1995).
7. Brownlee, K. A., Hodges, J. L., and Rosenblatt, M., The up and down method with small samples. American Statistical Association Journal, 262-277 (1953).
8. Bruce, R. D., An up and down procedure for acute toxicity testing. Fundamental and Applied Toxicology, 5, 151-157 (1985).
9. Chapman, J. M., Jr., Cocolas, G. H., and Hall, I. H., Hypolipidemic activity of phthalimide derivatives. 1. N-substituted phthalimide derivatives. J. Med. Chem., 22, 1399-1402 (1979).
10. Chapman, J. M., Jr., Cocolas, G. H., and Hall, I. H., Hypolipidemic activity of phthalimide derivatives. IV: Further chemical modification and investigation of the hypolipidemic activity of N-substituted imides. Journal of Pharmaceutical Sciences, 72, 1344-1347 (1983).
11. Chapman, J. M, Jr., Wyrick S. D., Voorstad P. J., Maguire, G. H., Cocolas, G. H., and Hall, I. H., Hypolipidemic activity of phthalimide derivatives. V: Reduced and hydrolytic products of simple cyclic amides. Journal of Pharmaceutical Sciences, 73, 1482-1484 (1984).
12. Dunham, N. W. and Miya, T. S., A note on a simple apparatus for detecting neurological deficit in rats and mice. Journal of the American Pharmaceutical Association, XLVI, 208-209 (1957).
13. Hall, I. H., Voorstad P. J., Chapman, J. M, and Cocolas, G. H., Antihyperlipidemic activity of phthalimide analogues in rodents. Journal of Pharmaceutical Sciences, 72, 845-851 (1983).
14. Hashimoto, Y., Novel biological response modifiers derived from thalidomide. Curr. Med. Chem., 5, 163-178 (1998).
15. Hashimoto, Y., Structural development of biological response modifiers based on thalidomide. Bioorg. Med. Chem., 10, 461-479 (2002).
16. oct from structures. Chem. Rev., 63, 1281-1306 (1993).
17. Maryanoff, B. E., Costanzo, M. J., Nortey, S. O., Greco, M. N., Shank, R. P., Schupsky, J. J., Ortegon, M. P., and Vaught, J. L., Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives. J. Med. Chem., 41, 1315-1343 (1998).
18. Miyachi, H., Azuma, A., Kitamoto, T., Hayashi, K., Kato, S., Koga, M., Sato, B., and Hashimoto, Y., Potent novel nonsteroidal androgen antagonists with a phthalimide skeleton. Bioorg. Med. Chem. Lett., 7, 1483-1488 (1997).
19. Moore, M. B. and Rapala, R. T., N-alkamine substituted phthalimides. J. Amer. Chem. Soc., 68, 1657-1658 (1946).
20. Pandeya, S. N., Aggarwal, N., and Jain, J. S., Evaluation of semicarbazones for anticonvulsant and sedative-hypnotic properties. Pharmazie, 54, 300-302 (1999).
21. Shibata, Y., Shichita, M., Sasaki, K., Nishimura, K., Hashimoto, Y., and Iwasaki, S., N-alkylphthalimides: Structural requirements of thalidomidal action on 12-O- tetradecanoylphorbol-13-acetate induced tumor necrosis factor α production by human leukemia HL-60 cells. Chem. Pharm. Bull., 43, 177-179 (1995).
22. Shimazawa, R., Miyachi, H., Takayama, H., Kuroda, K., Kato, F., Kato, M., Hashimoto, Y., Antiangiogenic activity of tumor necrosis factor-α- production regulators derived from thalidomide. Biol. Pharm. Bull., 22, 224-226 (1999).
23. Sou, S., Mayumi, S., Takahashi, H., Yamasaki, R., Kadoya, S., Sodeoka M., and Hashimoto, Y., Novel α-glucosidase inhibitors with a tetrachlorophthalimide skeleton. Bioorg. Med. Chem. Lett., 10, 1081-1084 (2000).
24. Swinyard, E. A., "Assay of antiepileptic drug activity in experimental animals" Standard tests in "Anticonvulsant drugs, International encyclopedia of Pharmacology and therapeutics" section 19, volume 1, Ed. By J. Mercier, Pergamon press, Oxford/ New York. pp 47-65 (1972).
25. Takahashi, H., Sou, S., Yamasaki, R., and Sodeoka, M., Hashimoto Y. α-Glucosidase inhibitors with a phthalimide skeleton: Structure-activity relationship study. Chem. Pharm. Bull., 48, 1494-1499 (2000).
26. Usifoh, C. O., Lambert, D. M., Wouters, J., and Scriba, G. K., Synthesis and anticonvulsant activity of N,N-phthaloyl derivatives of central nervous system inhibitory amino acids. Arch. Pharm., 334, 323-331 (2001).